SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-040399
Filing Date
2022-07-20
Accepted
2022-07-20 07:14:03
Documents
15
Period of Report
2022-07-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea163085-8k_adialpharma.htm   iXBRL 8-K 60404
2 PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON JULY 20, 2022 ea1630859ex99-1_adialpharma.htm EX-99.1 34284
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3994
  Complete submission text file 0001213900-22-040399.txt   330591

Data Files

Seq Description Document Type Size
4 XBRL DEFINITION FILE adil-20220720_def.xml EX-101.DEF 26516
5 XBRL LABEL FILE adil-20220720_lab.xml EX-101.LAB 36424
6 XBRL PRESENTATION FILE adil-20220720_pre.xml EX-101.PRE 25140
7 XBRL SCHEMA FILE adil-20220720.xsd EX-101.SCH 3434
9 EXTRACTED XBRL INSTANCE DOCUMENT ea163085-8k_adialpharma_htm.xml XML 5259
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 221092740
SIC: 2834 Pharmaceutical Preparations